Apex Biotechnology Corp. · TWSE:1733
Apex Biotechnology — Investor Conference (August 2021)
16 slides from Apex Biotechnology's conference presentation, Aug 25, 2021
Slide 1: ApexBio 2021 Aug
BYE 2h APEXBIO aiwan 2021 Aug APEXBIO
Slide 2: Company profile
Company profile Stock # TSEC 1733 Industry IVD Medical Device Head quarter: No. 7, Li-Hsin 5th Rd., Hsinchu Science Park, Hsinchu, Taiwan Operation Tao Yuan Factory: No. 180, Lane 70, Wuqing Rd., Dayuan Dist., Locations Taoyuan City 337, Taiwan Suzhou Corp.: Room 106, No.2, Kecheng Road, SIP, Suzhou
Slide 3: Milestone
Milestone 1997 ApexBio set-up 2007 Lactate launch 2017 Acquired Omnis Health LLC 1998 BGM FDA 510K approval 2008 Voice BGM launch Brazil ANVISA notified 1999 Uric Acid patent granted 2009 Taoyuan factory set-up 2018 ivCGM production set-up 2000 IPO listed to Taiwan OTC 2010 Tele-health tech build-up
Slide 4: Quality system
Quality system Region The Authority Regulatory compliance Taiwan TFDA GMP ISO 13485:2016 EU CE CE mark number:CE0197 EN ISO 15197:2015 510K’s USA FDA FDA on-site audit w/o 483 citations 2001/2006/2011/2016 China CFDA Medical Device Class II Japan PMDA Brazil ANVISA 2017 passed on-site audit
Slide 5: ESH policy
ESH policy In response to environmental protection and occupational safety and health policies, management procedures have been established year by year to consistently comply with the GRI guidelines in order to achieve the goal of sustainable of enterprises.
Slide 6: Product portfolio
Product portfolio Blood glucose monitoring systems Professional Monitoring systems Uric Acid Hemoglobin Lactate Ketone HbA1C Multi-functional systems Glucose + Glucose + Glucose + Uric Acid Ketone Cholesterol
Slide 7: GLUCOSURE POC
GLUCOSURE POC Glucose/Ketone POC barcode scanner + wifi Ketone POC barcode scanner + wifi
Slide 8: MultiSure GCTU
MultiSure GCTU • Glucose 血糖 • Cholesterol 膽固醇 • Triglycerides 三酸甘油酯 • Uric Acid 尿酸
Slide 9: Eclipse PLUS
Eclipse PLUS For Clinic and Hospital
Slide 10: GlucoSure A1C
GlucoSure AIC HEMOGLOBIN Alc ANALYZER € Bluetooth’ Enzymatic Electrochemistry APEXBIO Home use APEXBIO
Slide 11: Customized projects
Customized projects strip Product platform focus on electrochemistry/ photometry/immunology To derive new parameter tests and optimize our meter core platform. Sharing our advantage of regulation/quality control/ sales channels/clinical trails/manufacturing to alliance Systematic with partners
Slide 12: Global sales distribution
Global sales distribution Territory 2019 2020 2021/1H America 41% 42% 44% EU 48% 46% 45% Asia 10% 11% 10% Africa 1% 1% 1%
Slide 13: Finance Performance
Finance Performance 2019 2020 2021/1H Revenue 2,198,862 2,005,337 1,060,873 Gross margin 590,577 452,224 277,368 Operation profit 203,276 103,328 99,584 Profit after tax 112,978 94,629 56,593 EPS 1.14 0.95 0.57 G/M ratio 27% 22% 26% Shipped Meter Qty (kit) 1,800K 1,731K 837K Shipped Strip Qty(pcs) 1
Slide 14: Product ratio
Product ratio 2020 2021/ 1H BGM & A1C Electrode BGM & A1C Electrode Non-BGM 其他(附件) Non-BGM Others 4% 4% 9% 10% 16% 17% 71% 69% Non-BGM Hemoglobin/Ketone/UricAcid/Lactate/Cholesterol/ Pesticide quick check etc
Slide 15: Corporate Governance Evaluation (2020)
th the 7 Corporate Governance Evaluation (2020) Number of Points for Total number inapplicable Extra Credit Category weighting satisfied of indicators indicators Indicators: indicators Year 2019 2020 2019 2020 2019 2020 2019 2020 2019 2020 Protecting Shareholder Rights and Interests and Treating Sha
Slide 16: Thank you
Thank you APEXBIO
Apex Biotechnology — Investor Conference (August 2021) on 6ix